CurrentKaiser PermanentePolicy 03-33

Review Criteria Georgia Region

Defines indications, contraindications, and evidence-based recommendation for use of positive pressure (Meniett) device in treating Meniere's disease for Kaiser Permanente Georgia Region utilization management decisions.

Policy Summary

PayerKaiser Permanente

PolicyReview Criteria Georgia Region

Policy CodePolicy 03-33

Change TypeReviewed/Revised

Effective DateDec 12, 2008

Next Review Date

Key ActionIf considered despite recommendation against, submit a letter of necessity from the treating ENT documenting severe disease and failure of standard therapy for review.

POLICY UPDATE CHANGES

Last revision date recorded as 8/8/24; criteria type listed as Reviewed/Revised.

1Primary Diagnosis Code Listed

2HCPCS/Supply Codes Listed

1Policy Recommendation

Coverage Summary

Subject: Meniett low-pressure pulse generator (positive pressure therapy) for Meniere's disease. Scope summary: Defines indications, contraindications, and evidence-based recommendation for use of the Meniett device in treating Meniere's disease for Kaiser Permanente Georgia Region utilization management decisions. Policy number: 03-33. Effective date: 12/12/2008. Last review/revision: 08/08/2024. Status: CURRENT. Quick counts: primary diagnosis code listed (ICD-10 H81.09) and HCPCS/supply indicator codes (E2120, A4638) are recorded for utilization review.

Medical-Necessity Criteria

Covered / Not Covered Criteria

Policy-level recommendation and conditions considered for use of positive pressure therapy (Meniett):

ALL of the following

Diagnosis requirement
- Primary diagnosis: Diagnosis of Meniere's disease (ICD-10 H81.09)
Consideration of use only when ALL of the following are met
- Severe disease: Severe Meniere's disease
- Failed standard therapy: No significant improvement with standard therapy (e.g., low sodium diet, diuretics, stress management)
- Documentation: Letter of necessity from the treating ENT physician
Contraindications / Exclusions
- Inadequate trial exclusion: Inadequate trial of standard therapy
  If standard therapy has not been adequately tried, therapy is contraindicated
- Experimental/investigational: Considered experimental/investigational with exceptions for difficult cases
  Policy considers Meniett generally experimental/investigational with possible exceptions in difficult cases

ref_title_or_id_if_available__do_not_edit_please_rename_to_ref_field_if_needed_1234__ref?__ref__e46745a0-2f94-4f30-b6f5-6f3e2f3c0c7f_?__ref12345__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?

ref_name___do_not_use__use_ref_field_instead__please_remove_me____ref_field_b1_0_12345__ref__b1_0__ref__b1_0__ref__b1_0__ref__b1_0__ref__b1_0__ref__b1_0__ref__b1_0__ref__b1_0__ref__b1_0__ref__b1_0__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?__ref__?

ref_b1_0__should_be_here__please_replace_this_field_with_ref_only__b1_0

ref

b1_0

title

Covered / Not Covered Criteria

nodes

Aggregate evidence quality is reported as Grade B from a Cochrane systematic review and two small randomized controlled trials, with a high level of confidence in the evidence. The evidence base includes RCTs, systematic reviews/meta-analyses, and prospective studies with methodological limitations. Reported adverse event rate for middle ear infection is approximately 13.5%. Clinical rationale: randomized trials and systematic reviews do not demonstrate a clear benefit of Meniett over control for vertigo and hearing outcomes; meta-analyses are mixed, long-term efficacy is uncertain, and studies are limited by potential bias, small size, and inability to separate treatment effect from natural disease course.

Not Covered / Experimental

Coverage stance: not_covered_cosmetic — policy-level recommendation against prescribing positive pressure therapy (Meniett device) for Meniere's disease based on systematic review and randomized trials showing ineffectiveness. Operational implication: therapy is considered experimental/investigational and claims may be denied as not medically necessary; however, the policy acknowledges limited exceptions for difficult cases. If considered despite the recommendation, a letter of necessity from the treating ENT physician documenting severe disease and failure of standard therapy is required for review, and use is only considered when listed indications are met and contraindications (e.g., inadequate trial of standard therapy) are excluded.

Provider Actions / Prior Authorization

Documentation Required

Letter of necessity required

If Meniett therapy is being considered despite the policy recommendation against routine use, a letter of medical necessity from the treating ENT physician is required for review. The letter must document that the patient has severe Meniere's disease and has failed standard therapy (for example, low-sodium diet, diuretics, stress management) before positive pressure therapy will be considered.

Denial Risk

Coverage denial likely

Claims for positive pressure (Meniett) therapy may be denied as experimental/investigational or not medically necessary. The policy issues a recommendation against prescribing positive pressure therapy based on a Cochrane systematic review and randomized trials showing no effect, and notes limited and mixed evidence of benefit with risks such as middle ear infections.

Background

Background: The Meniett device is a transtympanic low-pressure pulse generator that delivers low-frequency, low-amplitude pressure pulses to the middle ear through a ventilation tube to theoretically evacuate inner-ear fluid and relieve vertigo. Trials and systematic reviews show mixed to negative results: some patients may experience reduced vertigo episodes, but overall randomized trials and reviews do not establish consistent benefit, and meta-analyses are conflicting. Adverse events reported include middle ear infections (approximately 13.5%) and the need for ventilation tube replacement over time. Long-term efficacy remains uncertain and additional well-designed, larger randomized placebo-controlled trials with longer follow-up are needed.

Evidence metrics

Aggregate evidence qualityGrade B (Cochrane SR + 2 small RCTs showing no effect)

Level of confidenceHigh

OpenPayer